Reminder of roflumilast psychiatric ADRs

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1386, 2012-01, pp. : 4-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Varenicline: numerous psychiatric ADRs reported in Australia

By  

Inpharma, Vol. 1, Iss. 1667, 2008-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Effect of Fluvoxamine on the Pharmacokinetics of Roflumilast and Roflumilast N -Oxide

By Oliver von Richter  

Clinical Pharmacokinetics, Vol. 46, Iss. 7, 2007-01 ,pp. : 613-622

Adis International

Access to resources Recommend Favorite

Pharmacokinetic evaluation of roflumilast

By Lahu Gezim   Nassr Nassr   Hünnemeyer Andreas  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 12, 2011-12 ,pp. : 1577-1591

Informa Healthcare

Access to resources Recommend Favorite

Roflumilast a real contender for COPD

By  

Inpharma, Vol. 1, Iss. 1548, 2006-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

Roflumilast promising in COPD and asthma

By  

Inpharma, Vol. 1, Iss. 1364, 2002-01 ,pp. : 9-10

Adis International

Access to resources Recommend Favorite